( University of Cincinnati Academic Health Center ) A new study at the University of Cincinnati seeks to end the questions over generic-vs.-brand for a common immunosuppressive drug for transplant patients, tacrolimus. Rita Alloway, PharmD, UC research professor of medicine, has received a $2.7 million US Food and Drug Administration grant to run a clinical trial studying the immunosuppressant ...
